Cargando…
Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports
BACKGROUND: The Cochrane risk of bias tool is a prominent instrument used to evaluate potential biases in clinical trials. In three updates of our Cochrane review on neuraminidase inhibitors, we assessed risk of bias on the same trials using different levels of detail: the trials in journal publicat...
Autores principales: | Jefferson, Tom, Jones, Mark A, Doshi, Peter, Del Mar, Chris B, Hama, Rokuro, Thompson, Matthew J, Onakpoya, Igho, Heneghan, Carl J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179405/ https://www.ncbi.nlm.nih.gov/pubmed/25270852 http://dx.doi.org/10.1136/bmjopen-2014-005253 |
Ejemplares similares
-
Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports
por: Doshi, Peter, et al.
Publicado: (2013) -
Effectiveness, safety and costs of orphan drugs: an evidence-based review
por: Onakpoya, Igho J, et al.
Publicado: (2015) -
Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials
por: Onakpoya, Igho J, et al.
Publicado: (2019) -
Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments
por: Jefferson, Tom, et al.
Publicado: (2014) -
Outcome reporting bias in Cochrane systematic reviews: a cross-sectional analysis
por: Shah, Kieran, et al.
Publicado: (2020)